AURKA and Miyoshi myopathy: Taken together, significant downregulation of AURKA by DCCT may provide additional strategies to combat MM, because it may either prohibit tumorigenesis through inhibiting chromosome segregation anomalies or improve the sensitivity of cancer cells to chemotherapeutics in the clinic.